Idorsia Ltd

Research Idorsia Ltd (IDIA) on Bullrun: market cap CHF 1.90B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerIDIA
• ExchangeSW
• CountrySwitzerland
• SectorHealthcare
• IndustryBiotechnology
• CurrencyCHF
• Market capCHF 1.90B
• Financial periodQ1 2026
• RevenueCHF 57.39M
• Net income-CHF 45.70M
• Free cash flow-CHF 28.25M
• Gross margin86.0%

Valuation Snapshot

latest market cap is CHF 1.90B.

About Idorsia Ltd

Idorsia Ltd, a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland, the United States, Japan, Europe, China, and Canada. The company has a clinical development pipeline for various therapeutic areas, such as CNS, cardiovascular, immunological disorders, and orphan diseases. It offers QUVIVIQ (daridorexant) for the treatment of insomnia.

Frequently asked questions

What is Idorsia Ltd's market cap?

Idorsia Ltd's market capitalization is CHF 1.90B.

What does Idorsia Ltd do?

Idorsia Ltd, a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland, the United States, Japan, Europe, China, and Canada.